The APP/PS1 mouse model used in our study possesses concurrent mutated forms of APP and Presenilin 1 (PS1), both identified separately in human Alzheimer diseases [1]. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.